Ryan Lebreton, OD
Optometrist · The Dalles, ORNPI 1528042769
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,100 of the $12,628 with a category attached, or 64.1%. Maculogix, Inc. accounts for 91.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $10,609 and has fallen 97.9% since, to $222 in 2025. Among optometrist clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 44 payments — averaging $287.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Maculogix, Inc.$12K
- Alcon$538
- LKC Technologies, Inc.$241
- Bausch & Lomb, A Division Of Bausch Health US, LLC$129
- Optos, Inc.$53
- Carl Zeiss Meditec AG$39
- plus $61 from 3 others
What the payments were for
- Consulting fees$1,0508%
- Speaking & faculty fees$8,10064%
- Food & beverage$3,43927%
- Gifts$390%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Maculogix, Inc. | 10 | $11,567 |
| Alcon | 21 | $538 |
| LKC Technologies, Inc. | 4 | $241 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $129 |
| Optos, Inc. | 1 | $53 |
| Carl Zeiss Meditec AG | 2 | $39 |
| Coopervision Inc. | 2 | $31 |
| Biotissue Holdings Inc. | 1 | $18 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AdaptDx$11,398
- TOTAL30$107
- Precision7$102
How this compares
$12,628 in reported general payments places this provider in the 95th percentile of 684 optometrist providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Travoprost | 13 | $1,787 |
| Prednisolone Acetate | 24 | $834 |
| Bimatoprost | 13 | $469 |
| Latanoprost | 45 | $407 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 19 | $317 |
| Acyclovir | 12 | $309 |
Paid to pharmacies, not to this prescriber.
Other optometrist in The Dalles
- Amber DunnKing City$284K
- Roger TabbPortland$239K
- Mila IoussifovaPortland$223K
- Cristina SchniderForest Grove$204K
- Tracy DollPortland$164K
- Yue LiuForest Grove$139K
- Shajida Espat ReichMedford$87K
- Bradley SmithTigard$85K
- Christi ClossonForest Grove$80K
- Frank ZhengForest Grove$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.